Peroxisomal proliferator-activated receptor-α protects renal tubular cells from doxorubicin-induced apoptosis

Molecular Pharmacology

Volumn 72, Issue 5, 2007, Pages 1238-1245

  Lin, Heng ^b,c   Hou, Chun Cheng ^a   Cheng, Ching Feng ^b,c,d   Chiu, Ted H ^b   Hsu, Yung Ho ^a   Sue, Yuh Mou ^a   Chen, Tso Hsiao ^a   Hou, Hsin Han ^c   Chao, Ying Chi ^c   Cheng, Tzu Hurng ^a   Chen, Cheng Hsien ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TZU CHI UNIVERSITY   (Taiwan)

^c INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^d BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CYCLOOXYGENASE 1 INHIBITOR; DOXORUBICIN; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PROSTACYCLIN; PROSTACYCLIN SYNTHASE; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; GEL ELECTROPHORESIS; GENETIC TRANSFECTION; IMMUNOBLOTTING; IMMUNOPRECIPITATION; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT;

ADENOVIRIDAE; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; CELL LINE; CYCLOOXYGENASE 1; CYTOCHROME P-450 ENZYME SYSTEM; CYTOPROTECTION; DOXORUBICIN; HUMANS; INTRAMOLECULAR OXIDOREDUCTASES; KIDNEY TUBULES, PROXIMAL; PPAR ALPHA; RATS; REACTIVE OXYGEN SPECIES; RNA, MESSENGER; TRANSFECTION;

EID: 35548981840     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.107.037523     Document Type: Article

References (30)

1. Bertani T, Poggi A, Pozzoni R, Delaini F, Sacchi G, Thoua Y, Mecca G, Remuzzi G, and Donati MB (1982) Adriamycin-induced nephrotic syndrome in rats: sequence of pathologic events. Lab Invest 46:16-23.
2. Bonizzi G, Piette J, Merville MP, and Bours V (2000) Cell type-specific role for reactive oxygen species in nuclear factor-kappaB activation by interleukin-1. Biochem Pharmacol 59:7-11.
3. Chen CH, Lin H, Hsu YH, Sue YM, Cheng TH, Chan P, and Chen TH (2006) The protective effect of prostacyclin on Adriamycin-induced apoptosis in rat renal tubular cells. Eur J Pharmacol 529:8-15.
4. Cheng CY, Sue YM, Chen CH, Hou CC, Chan P, Chu YL, Chen TH, and Hsu YH (2006) Tetramethylpyrazine attenuates Adriamycin-induced apoptotic injury in rat renal tubular cells NRK-52E. Planta Med 72:888-893.
5. Delerive P, De Bosscher K, Besnard S, Vanden Berghe W, Peters JM, Gonzalez FJ, Fruchart JC, Tedgui A, Haegeman G, and Staels B (1999) Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-κB and AP-1. J Biol Chem 274:32048-32054.
6. Delerive P, Gervois P, Fruchart JC, and Staels B (2000) Induction of IκBαexpression as a mechanism contributing to the anti-inflammatory activities of peroxisome proliferator-activated receptor-α activators. J Biol Chem 275:36703-36707.
7. Duval C, Chinetti G, Trottein F, Fruchart JC, and Staels B (2002) The role of PPARs in atherosclerosis. Trends Mol Med 8:422-430.
8. Forman BM, Chen J, and Evans RM (1997) Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ. Proc Natl Acad Sci U S A 94:4312-4317.
9. Gupta RA, Tan J, Krause WF, Geraci MW, Willson TM, Dey SK, and DuBois RN (2000) Prostacyclin-mediated activation of peroxisome proliferator-activated receptor δ in colorectal cancer. Proc Natl Acad Sci U S A 97:13275-13280.
10. Hatae T, Wada M, Yokoyama C, Shimonishi M, and Tanabe T (2001) Prostacyclin-dependent apoptosis mediated by PPAR δ. J Biol Chem 276:46260-46267.
11. Issemann I and Green S (1990) Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 347:645-650.
12. Khan S, Cleveland RP, Koch CJ, and Schelling JR (1999) Hypoxia induces renal tubular epithelial cell apoptosis in chronic renal disease. Lab Invest 79:1089-1099.
13. Kliewer SA, Forman BM, Blumberg B, Ong ES, Borgmeyer U, Mangelsdorf DJ, Umesono K, and Evans RM (1994) Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc Natl Acad Sci U S A 91:7355-7359.
14. Lee GY, Kim NH, Zhao ZS, Cha BS, and Kim YS (2004) Peroxisomal- proliferator-activated receptor alpha activates transcription of the rat hepatic malonyl-CoA decarboxylase gene: a key regulation of malonyl-CoA level. Biochem J 378:983-990.
15. Lim H and Dey SK (2002) A novel pathway of prostacyclin signaling-hanging out with nuclear receptors. Endocrinology 143:3207-3210.
16. Lim H, Gupta RA, Ma WG, Paria BC, Moller DE, Morrow JD, DuBois RN, Trzaskos JM, and Dey SK (1999) Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARdelta. Genes Dev 13:1561-1574.
17. Lim H, Paria BC, Das SK, Dinchuk JE, Langenbach R, Trzaskos JM, and Dey SK (1997) Multiple female reproductive failures in cyclooxygenase 2-deficient mice. Cell 91:197-208.
18. Lin H, Lin TN, Cheung WM, Nian GM, Tseng PH, Chen SF, Chen JJ, Shyue SK, Liou JY, Wu CW, et al. (2002) Cyclooxygenase-1 and bicistronic cyclooxygenase-1/prostacyclin synthase gene transfer protect against ischemic cerebral infarction. Circulation 105:1962-1969.
19. Lin Q, Ruuska SE, Shaw NS, Dong D, and Noy N (1999) Ligand selectivity of the peroxisome proliferator-activated receptor alpha. Biochemistry 38:185-190.
20. Müller I, Niethammer D, and Bruchelt G (1998) Anthracycline-derived chemotherapeutics in apoptosis and free radical cytotoxicity. Int J Mol Med 1:491-494.
21. Nagothu KK, Bhatt R, Kaushal GP, and Portilla D (2005) Fibrate prevents cisplatin-induced proximal tubule cell death. Kidney Int 68:2680-2693.
22. Okuda S, Oh Y, Tsuruda H, Onoyama K, Fujimi S, and Fujishima M (1986) Adriamycin-induced nephropathy as a model of chronic progressive glomerular disease. Kidney Int 29:502-510.
23. Schelling JR, Nkemere N, Kopp JB, and Cleveland RP (1998) Fas-dependent fratricidal apoptosis is a mechanism of tubular epithelial cell deletion in chronic renal failure. Lab Invest 78:813-824.
24. Scholey JW, Miller PL, Rennke HG, and Meyer TW (1989) Effect of converting enzyme inhibition on the course of Adriamycin-induced nephropathy. Kidney Int 36:816-822.
25. Shyue SK, Tsai MJ, Liou JY, Willerson JT, and Wu KK (2001) Selective augmentation of prostacyclin production by combined prostacyclin synthase and cyclooxygenase-1 gene transfer. Circulation 103:2090-2095.
26. Singal PK, Li T, Kumar D, Danelisen I, and Iliskovic N (2000) Adriamycin-induced heart failure: mechanism and modulation. Mol Cell Biochem 207:77-86.
27. Smirnov AN (2002) Nuclear receptors: nomenclature, ligands, mechanisms of their effects on gene expression. Biochemistry (Mosc) 67:957-977.
28. Vane JR and Botting RM (1995) Pharmacodynamic profile of prostacyclin. Am J Cardiol 75:3A-10A.
29. Yang T, Michele DE, Park J, Smart AM, Lin Z, Brosius FC 3rd, Schnermann JB, and Briggs JP (1999) Expression of peroxisomal proliferator-activated receptors and retinoid X receptors in the kidney. Am J Physiol 277:F966-F973.
30. Zhang J, Clark JR Jr, Herman EH, and Ferrans VJ (1996) Doxorubicin-induced apoptosis in spontaneously hypertensive rats: differential effects in heart, kidney and intestine, and inhibition by ICRF-187. J Mol Cell Cardiol 28:1931-1943.